WilliamBFisherMD

PubMed

• 53 citations
  Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation w...
  Shadia I. Jalal, H. D. Riggs, Anton Melnyk, Donald A. Richards, A. K. Agarwala, Marcus A. Neubauer, Rafat Ansari, Ramaswamy Govindan, D. Bruetman, William B. Fisher, T...> ;Annals of Oncology. 2012 Jul 1
• Sunitinib Plus Paclitaxel in Patients with Advanced Esophageal Cancer: A Phase II Study from the Hoosier Oncology Groupe.
  Schmitt, J. M., Sommers, S. R., Fisher, W., Ansari, R., Robin, E., Koneru, K., McClean, J., Liu, Z., Tong, Y., Hanna, N.> ;J Thorac Oncol. 2012 Apr
• Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.
  Schmitt JM, Sommers SR, Fisher WB, Ansari RH, Robin EL, Koneru K, McClean JW, Liu Z, Hanna NH> ;J. Clin. Oncol.. 2011-05-20
• Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/...
  Casey EM, Harb W, Bradford D, Bufill J, Nattam S, Patel J, Fisher W, Latz JE, Li X, Wu J, Hanna N> ;J Thorac Oncol. 2010-11-01
• Randomized, double blind, multicenter, phase II study of pemetrexed (PEM), carboplatin (CARBO), bevacizumab (BEV) with enzastaurin (ENZ) or placebo (PBO) in chemothera...
  Casey EM, Harb W, Bradford D, Bufill J, Nattam S, Patel J, Fisher W, Latz JE, Wu J, Hanna N> ;J. Clin. Oncol.. 2009-05-20
• 26 citations
  Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study
  Shadia I. Jalal, Rafat Ansari, Ramaswamy Govindan, Sumeet Bhatia, D. Bruetman, William B. Fisher, Gregory A. Masters, Angela White, Daniel G. Stover, Menggang Yu, Nass...> ;Journal of Thoracic Oncology. 2009 Jan 1
• 19 citations
  Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
  Anuj K. Agarwala, William B. Fisher, D. Bruetman, John McClean, David Taber, Michael L. Titzer, Beth E. Juliar, Menggang Yu, T. Breen, Lawrence H. Einhorn, Nasser H. H...> ;Journal of Thoracic Oncology. 2008 Apr 1
• 33 citations
  Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myelo...
  Attaya Suvannasankha, Christopher A. Fausel, Beth E. Juliar, Constantin T. Yiannoutsos, William B. Fisher, Rafat Ansari, Lisa L. Wood, Gina G. Smith, Larry D. Cripe, R...> ;The Oncologist. 2007 Jan 1
• Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer (NSCLC): A phase II study from the Hoosier Oncology Group.
  Agarwala AK, Einhorn L, Fisher W, Bruetman D, McClean J, Taber D, Titzer M, Juliar B, Breen T, Hanna N> ;J. Clin. Oncol.. 2006-06-20
• 6 citations
  A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study.
  Kristen N. Ganjoo, Michael J. Robertson, William B. Fisher, Sin-Ho Jung, J. McClean, Sang Yoon Huh, Jose Bufill, Sheron Williams, Larry D. Cripe> ;American Journal of Clinical Oncology. 2005 Apr 1
• 14 citations
  Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (H...
  Nasser H. Hanna, Rafat Ansari, William B. Fisher, Jianzhao Shen, Sin-Ho Jung, Alan B. Sandler> ;Lung Cancer. 2002 Mar 1
• 119 citations
  Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
  Patrick J. Loehrer, Rafat Ansari, René Gonin, Frank Monaco, William E. Fisher, Alan Sandler, Lawrence H. Einhorn> ;Journal of Clinical Oncology. 1995 Oct 1
• 116 citations
  Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
  C Blanke, Rafat Ansari, R. Mantravadi, René Gonin, R. Tokars, William E. Fisher, K. Pennington, T. O'Connor, S Rynard, Michael E. Miller> ;Journal of Clinical Oncology. 1995 Jun 1
• 2 citations
  Phase II trial of high-dose cisplatin plus etoposide plus vinblastine in non-small-cell lung cancer. A Hoosier Oncology Group study.
  Elizabeth Eklund, Michael E. Miller, Rafat Ansari, William B. Fisher, Lawrence H. Einhorn> ;American Journal of Clinical Oncology. 1991 Oct 1
• 15 citations
  Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology Group
  Bruce J. Roth, George W. Sledge, Stephen D. Williams, Steven C. Meyer, Rafat Ansari, William B. Fisher> ;Cancer. 1991 Jul 15
• 28 citations
  Clinical trials in cancer therapy: Efforts to improve patient enrollment by community oncologists
  William B. Fisher, Stuart J. Cohen, Monica K. Hammond, Sandra Turner, Patrick J. Loehrer> ;Medical and Pediatric Oncology. 1991 Jan 1
• 104 citations
  Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
  Lawrence H. Einhorn, Patrick J. Loehrer, Stephen D. Williams, S Meyers, T Gabrys, S R Nattan, R Woodburn, R. E. Drasga, J Songer, William E. Fisher> ;Journal of Clinical Oncology. 1986 Jul 1
• Join now to see all